GlassScriptPhysician profile
Alan Jay Gottlieb
NPI 1669424966
$664.69
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $33.66 · 2021: $34.44 · 2022: $108 · 2023: $161 · 2024: $82.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224 · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.47 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $166.97 | 2019 | |
| Abbvie INC. | $118.85 | 2019-2024 | |
| Beta Bionics, INC. | $77.28 | 2023-2024 | Ilet Bionic Pancreas |
| Novo Nordisk INC | $68.01 | 2022 | |
| Aurinia Pharma U.S., INC. | $39.38 | 2021-2022 | |
| Astellas Pharma US INC | $29.89 | 2023 | Myrbetriq |
| Ultragenyx Pharmaceutical INC. | $24.76 | 2023 | |
| Novartis Pharmaceuticals Corporation | $20.50 | 2022 | |
| Sobi, INC | $19.25 | 2024 | |
| Medtronic Minimed, INC. | $19.11 | 2019 | |
| Amgen INC. | $19.04 | 2019 | |
| Lilly USA, LLC | $17.77 | 2023 | Jardiance |
| Cequr Corporation | $16.03 | 2023 | Cequr Simplicity |
| Ucb, INC. | $14.75 | 2021 | |
| Glaxosmithkline, LLC. | $13.10 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Gottlieb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.